Octreotide

Orphan Drug Cold Chain RequiredFDA Approved

Description

Octreotide is a synthetic somatostatin analog that mimics natural somatostatin pharmacologically. It is used to treat symptoms of neuroendocrine tumors and hormone-secreting tumors in multiple endocrine neoplasia syndromes. The drug effectively controls hormone hypersecretion and tumor-related symptoms.

Indications & Therapeutic Use

Acromegaly, carcinoid tumors, VIPomas, gastroenteropancreatic neuroendocrine tumors, multiple endocrine neoplasia

Linked Diseases:

Global Availability (10 countries)

CountryAccess RouteRegulatory PathwayLead TimeStatus
————
————
————
————
————
————
————
————
————
————

Buy / Source Octreotide — GNH India

182 matching products available through GNH India. Select a product to view details and request a quote on the GNH India website.

Browse all Octreotide products on GNH India

Products and ordering are fulfilled by GNH India. You will be redirected to www.gnhindia.com.

Available Through

This drug is available for procurement through the following fulfilment partner.

Fulfilment Partner
Octreotide
Generic NameOctreotide
Brands1 brand available
Active IngredientOctreotide acetate
Drug ClassAcromegaly
ManufacturerNovartis
Dosage FormsSubcutaneous/IV injection, 50mcg/mL, 100mcg/mL, 500mcg/mL; IM depot 10mg, 20mg, 30mg
Medical CodeH01CB02
Orphan StatusYes — Orphan Drug
Cold ChainRequired
Lead Time10 days
Reg. StatusFDA Approved
Clinical TrialNCT00004874
Countries10 countries
Authority Signals
Last Verified3/21/2026
Data ConfidenceHigh (AI + Pharmacist)
Source Citations11 Validated Nodes